July 26, 2024
California’s bill creating new restrictions on intoxicating hemp products has prompted responses citing negative impacts on patients and businesses.
July 16, 2024
This month’s webinar discussed studies conducted on cannabis and psychedelics for various conditions including anxiety and autism spectrum disorder.
July 12, 2024
Here, we discuss the importance of calibration metrics and how to measure calibration quality.
June 28, 2024
This review highlights an in-silico assessment of the binding interactions of pro-drug moiety analogs and an importance in identifying potential issues that would need further testing to ensure safety for consumers such as the hERG values which are pertinent in the pharmaceutical fields in whether or not drugs can be safe to use.
June 24, 2024
Here, Scott Mazza, Founder of Vitality CBD, compares the effects of the cannabis compounds CBD and THC for use with various conditions.
April 05, 2024
This article discusses the early experiments and studies on the effects of two cannabinoids on anxiety.
February 24, 2024
Here, we will introduce systematic error, discuss how to measure signal-to-noise ratios, and more.
As markets mature, manufacturing terpene blends have become a new art form and a differentiating factor for potential therapeutic applications. Here, we dive deeper into the insights of terpene formulation considerations.
January 30, 2024
In this blog installment, we take a deep dive into research on how cannabis affects neurodegenerative disorders such as Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease.
November 30, 2023
Japan is amending a piece of hemp legislation which will help expand rules regarding hemp but would restrict cannabis regulation.